ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway

Jiayu Ding(China Pharmaceutical University), Peng Yang(China Pharmaceutical University)

Advanced Science

June 20, 2025

10.1002/advs.202506718

Cited by 1

Related Papers

Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer

|Nature Communications|2022|18